CellaVision
212.5
SEK
+0.47 %
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
1,501 following
+0.47%
-2.3%
-1.16%
-26.85%
-14.66%
+0.47%
-34.66%
-36.57%
+1,262.18%
CellaVision is active in medical technology. The company's operations develop and market image analysis systems for diagnosing blood and other body fluids. The products are intended to replace traditional microscope analysis. Operations are conducted on a global level, primarily in the Nordic countries, Europe and North America, where customers consist of research institutes. The head office is located in Lund.
Read moreMarket cap
5.07B SEK
Turnover
1.8M SEK
Revenue
677.29M
EBIT %
24.66 %
P/E
38.92
Dividend yield-%
1.06 %
Financial calendar
6/2
2025
Annual report '24
29/4
2025
Interim report Q1'25
6/5
2025
General meeting '24
ShowingAll content types
Valberedning utsedd inför CellaVisions årsstämma 2025
Nomination Committee for the CellaVision Annual General Meeting 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools